{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:02:08Z","timestamp":1790391728076,"version":"4.1.0"},"reference-count":178,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.imbio.2021.152153","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T01:42:01Z","timestamp":1636335721000},"page":"152153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Diagnostic biomarkers of dilated cardiomyopathy"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8944-4123","authenticated-orcid":false,"given":"Aysan","family":"Moeinafshar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3836-1827","authenticated-orcid":false,"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.imbio.2021.152153_b0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007385","article-title":"Pro-inflammatory biomarkers in stable versus acutely decompensated heart failure with preserved ejection fraction","volume":"7","author":"Abernethy","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.imbio.2021.152153_b0010","doi-asserted-by":"crossref","unstructured":"Adela R, Banerjee SK. GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective. Ndisang JF, editor. J. Diabetes Res. [Internet]. 2015;2015:490842. Available from: https:\/\/doi.org\/10.1155\/2015\/490842.","DOI":"10.1155\/2015\/490842"},{"issue":"2","key":"10.1016\/j.imbio.2021.152153_b0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejheart.2005.06.008","article-title":"Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes","volume":"8","author":"Alla","year":"2006","journal-title":"Eur. J. Heart Fail."},{"issue":"10","key":"10.1016\/j.imbio.2021.152153_b0020","first-page":"709","article-title":"The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling","volume":"36","author":"Amorim","year":"2017","journal-title":"Rev Port Cardiol orgao Of da Soc Port Cardiol = Port J Cardiol an Off J Port Soc Cardiol"},{"issue":"3","key":"10.1016\/j.imbio.2021.152153_b0025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12265-020-10042-3","article-title":"The Role of Biomarkers in Cardio-Oncology","volume":"13","author":"Ananthan","year":"2020","journal-title":"J Cardiovasc Transl Res"},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0030","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1038\/s41598-021-82745-9","article-title":"The miRNA199a\/SIRT1\/P300\/Yy1\/sST2 signaling axis regulates adverse cardiac remodeling following MI","volume":"11","author":"Asensio-Lopez","year":"2021","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.imbio.2021.152153_b0035","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.3390\/nu12082401","article-title":"Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps","volume":"12","author":"Baczek","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.imbio.2021.152153_b0040","doi-asserted-by":"crossref","unstructured":"Bai W, Huang J, Zhu M, Liu X, Tao J. Association between elevated adiponectin level and adverse outcomes in patients with heart failure: a systematic review and meta-analysis. Brazilian J Med Biol Res = Rev Bras Pesqui medicas e Biol. 2019;52(7):e8416.","DOI":"10.1590\/1414-431x20198416"},{"issue":"7","key":"10.1016\/j.imbio.2021.152153_b0045","doi-asserted-by":"crossref","first-page":"44B","DOI":"10.1016\/j.amjcard.2015.01.040","article-title":"ST2 in Pulmonary Disease","volume":"115","author":"Bajwa","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.imbio.2021.152153_b0050","doi-asserted-by":"crossref","unstructured":"Balbaloglu O, Ozcan SS. Is pentraxin 3 level an effective biomarker in disease activity in patients with rheumatoid arthritis? Arch Med Sci [Internet]. 2020;16(1):81\u20136. Available from: https:\/\/doi.org\/10.5114\/aoms.2017.69726.","DOI":"10.5114\/aoms.2017.69726"},{"key":"10.1016\/j.imbio.2021.152153_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/3818292","article-title":"The Role of Serum Adiponectin for Outcome Prediction in Patients with Dilated Cardiomyopathy and Advanced Heart Failure","volume":"2017","author":"Baltr\u016bnien\u0117","year":"2017","journal-title":"Biomed Res. Int."},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00059-012-3714-x","volume":"38","author":"Ba\u015far","year":"2013","journal-title":"Herz"},{"issue":"2","key":"10.1016\/j.imbio.2021.152153_b0065","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cyto.2007.11.001","article-title":"Elevated levels of soluble ST2 protein in dengue virus infected patients","volume":"41","author":"Becerra","year":"2008","journal-title":"Cytokine [Internet]"},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0070","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacep.2017.12.003","article-title":"Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell-Cell Adhesion Structures","volume":"4","author":"Begay","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.imbio.2021.152153_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6644631","article-title":"Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes","volume":"2021","author":"Berezin","year":"2021","journal-title":"Dis. Markers"},{"key":"10.1016\/j.imbio.2021.152153_b0080","doi-asserted-by":"crossref","unstructured":"Bernardi S, Toffoli B, Bossi F, Candido R, Stenner E, Carretta R, et al. Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients. BMC Nephrol [Internet]. 2017;18(1):219. Available from: https:\/\/doi.org\/10.1186\/s12882-017-0625-3.","DOI":"10.1186\/s12882-017-0625-3"},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.108.844324","article-title":"Episodes of acute heart failure syndrome are associated with increased levels of troponin and extracellular matrix markers","volume":"3","author":"Biolo","year":"2010","journal-title":"Circ. Heart Fail."},{"issue":"2","key":"10.1016\/j.imbio.2021.152153_b0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.amjcard.2009.08.682","article-title":"Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"105","author":"Bistola","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/14017431.2014.917767","article-title":"High osteoprotegerin levels predict MACCE in STEMI patients, but are not associated with myocardial salvage","volume":"48","author":"Bjerre","year":"2014","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.imbio.2021.152153_b0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijcard.2016.10.038","article-title":"Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction","volume":"226","author":"Boulogne","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.imbio.2021.152153_b0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-3-319-57613-8_10","article-title":"Cardiac Autoimmunity: Myocarditis","volume":"1003","author":"Bracamonte-Baran","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.imbio.2021.152153_b0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijcard.2018.08.001","article-title":"Utility of temporal profiles of new cardio-renal and pulmonary candidate biomarkers in chronic heart failure","volume":"276","author":"Brankovic","year":"2019","journal-title":"Int. J. Cardiol."},{"issue":"22","key":"10.1016\/j.imbio.2021.152153_b0115","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126315","article-title":"Prelamin A mediates myocardial inflammation in dilated and HIV-associated cardiomyopathies","volume":"4","author":"Brayson","year":"2019","journal-title":"JCI insight"},{"key":"10.1016\/j.imbio.2021.152153_b0120","doi-asserted-by":"crossref","unstructured":"Brkic M, Balusu S, Libert C, Vandenbroucke RE. Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases. Valli\u00e8res L, editor. Mediators Inflamm [Internet]. 2015;2015:620581. Available from: https:\/\/doi.org\/10.1155\/2015\/620581.","DOI":"10.1155\/2015\/620581"},{"key":"10.1016\/j.imbio.2021.152153_b0125","doi-asserted-by":"crossref","unstructured":"Buonafine M, Martinez-Martinez E, Jaisser F. More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases. Clin Sci [Internet]. 2018 May 8;132(9):909\u201323. Available from: https:\/\/doi.org\/10.1042\/CS20171592.","DOI":"10.1042\/CS20171592"},{"issue":"35","key":"10.1016\/j.imbio.2021.152153_b0130","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","article-title":"Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease","volume":"38","author":"Caforio","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.imbio.2021.152153_b0135","doi-asserted-by":"crossref","first-page":"111066","DOI":"10.1016\/j.biopha.2020.111066","article-title":"Research progress on the role of gal-3 in cardio\/cerebrovascular diseases","volume":"133","author":"Cao","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.imbio.2021.152153_b0140","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.7150\/ijms.8083","article-title":"Comparison the prognostic value of galectin-3 and serum markers of cardiac extracellular matrix turnover in patients with chronic systolic heart failure","volume":"11","author":"Chang","year":"2014","journal-title":"Int J Med Sci"},{"issue":"3","key":"10.1016\/j.imbio.2021.152153_b0145","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1183\/09031936.00209911","article-title":"Matrix metalloproteinases and their inhibitors in pulmonary hypertension","volume":"40","author":"Chelladurai","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.imbio.2021.152153_b0150","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2010.09.052","article-title":"\u03b2-trace protein versus cystatin C: which is a better surrogate marker of renal function versus prognostic indicator in cardiovascular diseases?","volume":"57","author":"Chen","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.imbio.2021.152153_b0155","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181761","article-title":"Cystatin C for predicting all-cause mortality and rehospitalization in patients with heart failure: a meta-analysis","volume":"39","author":"Chen","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.imbio.2021.152153_b0160","doi-asserted-by":"crossref","unstructured":"Choi HM, Doss HM, Kim KS. Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases. Int J Mol Sci [Internet]. 2020 Feb 12;21(4):1219. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32059381.","DOI":"10.3390\/ijms21041219"},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011028","article-title":"Association Between Plasma Neutrophil Gelatinase-Associated Lipocalin and Cardiac Disease Hospitalizations and Deaths in Older Women","volume":"8","author":"Chong","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1023\/A:1016040925295","article-title":"Serum sFAS levels are elevated in ANCA-positive vasculitis compared with other autoimmune diseases","volume":"22","author":"Christensson","year":"2002","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imbio.2021.152153_b0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cyto.2019.03.017","article-title":"Pentraxin-3 in coronary artery disease: A meta-analysis","volume":"119","author":"Chu","year":"2019","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.imbio.2021.152153_b0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cardfail.2004.01.010","article-title":"Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure","volume":"10","author":"Cicoira","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.imbio.2021.152153_b0185","doi-asserted-by":"crossref","unstructured":"Morgenthaler NG. Copeptin: A Biomarker of Cardiovascular and Renal Function. Congest Hear Fail [Internet]. 2010 Jul 1;16(s1):S37\u201344. Available from: https:\/\/doi.org\/10.1111\/j.1751-7133.2010.00177.x.","DOI":"10.1111\/j.1751-7133.2010.00177.x"},{"key":"10.1016\/j.imbio.2021.152153_b0190","doi-asserted-by":"crossref","unstructured":"Corso A, Dovio A, Rusconi C, Sartori ML, Klersy C, Varettoni M, et al. Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls. Leukemia [Internet]. 2004;18(9):1555\u20137. Available from: https:\/\/doi.org\/10.1038\/sj.leu.2403429.","DOI":"10.1038\/sj.leu.2403429"},{"issue":"11","key":"10.1016\/j.imbio.2021.152153_b0195","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM200003163421104","article-title":"Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene","volume":"342","author":"Dalakas","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0200","first-page":"380","article-title":"A New and Interesting Prognostic Biomarker","volume":"29","author":"de la Carrillo-Esper","year":"2013","journal-title":"Med Int Mex"},{"issue":"9380","key":"10.1016\/j.imbio.2021.152153_b0205","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(03)13976-1","article-title":"B-type natriuretic peptide in cardiovascular disease","volume":"362","author":"de Lemos","year":"2003","journal-title":"Lancet (London, England)"},{"issue":"23","key":"10.1016\/j.imbio.2021.152153_b0210","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJM199412083312307","article-title":"Idiopathic dilated cardiomyopathy","volume":"331","author":"Dec","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.imbio.2021.152153_b0215","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.3748\/wjg.v17.i17.2181","article-title":"Soluble ST2: a new and promising activity marker in ulcerative colitis","volume":"17","author":"D\u00edaz-Jim\u00e9nez","year":"2011","journal-title":"World J Gastroenterol [Internet]"},{"key":"10.1016\/j.imbio.2021.152153_b0220","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3389\/fneur.2018.00904","article-title":"Elevated Soluble Fas and FasL in Cerebrospinal Fluid and Serum of Patients With Anti-N-methyl-D-aspartate Receptor Encephalitis [Internet]","volume":"9","author":"Ding","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.imbio.2021.152153_b0225","doi-asserted-by":"crossref","unstructured":"Djordjevi\u0107 V V, Risti\u0107 T, Lazarevi\u0107 D, \u0106osi\u0107 V, Vlahovi\u0107 P, Djordjevi\u0107 VB. Schizophrenia is associated with increased levels of serum Fas and FasL. Clin Chem Lab Med [Internet]. 2012;50(6):1049\u201354. Available from: https:\/\/doi.org\/10.1515\/cclm-2011-0684.","DOI":"10.1515\/cclm-2011-0684"},{"key":"10.1016\/j.imbio.2021.152153_b0230","doi-asserted-by":"crossref","unstructured":"Doughty L, Clark RSB, Kaplan SS, Sasser H, Carcillo J. sFas and sFas Ligand and Pediatric Sepsis-Induced Multiple Organ Failure Syndrome. Pediatr Res [Internet]. 2002;52(6):922\u20137. Available from: https:\/\/doi.org\/10.1203\/00006450-200212000-00018.","DOI":"10.1203\/00006450-200212000-00018"},{"key":"10.1016\/j.imbio.2021.152153_b0235","doi-asserted-by":"crossref","unstructured":"Eilenberg W, Stojkovic S, Piechota-Polanczyk A, Kaider A, Kozakowski N, Weninger WJ, et al. Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment. Cardiovasc Diabetol [Internet]. 2017;16(1):98. Available from: https:\/\/doi.org\/10.1186\/s12933-017-0579-6.","DOI":"10.1186\/s12933-017-0579-6"},{"issue":"6","key":"10.1016\/j.imbio.2021.152153_b0240","first-page":"796","article-title":"Association Between Increased Levels of Cystatin C and the Development of Cardiovascular Events or Mortality: A Systematic Review and Meta-Analysis","volume":"111","author":"Einwoegerer","year":"2018","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.imbio.2021.152153_b0245","doi-asserted-by":"crossref","unstructured":"Erturk A, Cure E, Parlak E, Cumhur Cure M, Baydur Sahin S, Yuce S. Clinical Significance of Neutrophil Gelatinase-Associated Lipocalin in Crimean-Congo Hemorrhagic Fever. L\u00e9one M, editor. Biomed Res Int [Internet]. 2015;2015:374010. Available from: https:\/\/doi.org\/10.1155\/2015\/374010.","DOI":"10.1155\/2015\/374010"},{"issue":"S1","key":"10.1016\/j.imbio.2021.152153_b0250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00059-019-4825-4","article-title":"Prevalence of TTN mutations in patients with dilated cardiomyopathy : A meta-analysisPr\u00e4valenz von TTN-Mutationen bei Patienten mit dilatativer Kardiomyopathie: Eine Metaanalyse","volume":"45","author":"Fang","year":"2020","journal-title":"Herz"},{"issue":"23","key":"10.1016\/j.imbio.2021.152153_b0255","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","article-title":"Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease","volume":"341","author":"Fatkin","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.imbio.2021.152153_b0260","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.hlc.2017.04.021","article-title":"Position Statement on the Diagnosis and Management of Familial Dilated Cardiomyopathy","volume":"26","author":"Fatkin","year":"2017","journal-title":"Hear Lung Circ [Internet]"},{"issue":"5","key":"10.1016\/j.imbio.2021.152153_b0265","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.ijcard.2012.05.101","article-title":"Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging","volume":"167","author":"Fuernau","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.imbio.2021.152153_b0270","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/cc7780","article-title":"Markers of collagen synthesis and degradation are increased in serum in severe sepsis: a longitudinal study of 44 patients","volume":"13","author":"G\u00e4ddn\u00e4s","year":"2009","journal-title":"Crit Care [Internet]"},{"issue":"21","key":"10.1016\/j.imbio.2021.152153_b0275","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/hrt.2011.227967","article-title":"Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinicopathological study","volume":"97","author":"Garcia-Pavia","year":"2011","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.imbio.2021.152153_b0280","doi-asserted-by":"crossref","first-page":"e3238","DOI":"10.1371\/journal.pone.0003238","article-title":"Circulating apoptotic progenitor cells in patients with congestive heart failure","volume":"3","author":"Geft","year":"2008","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.imbio.2021.152153_b0285","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/ten.2006.12.331","article-title":"Comparative analysis of methods for assessment of circulating endothelial progenitor cells","volume":"12","author":"George","year":"2006","journal-title":"Tissue Eng."},{"issue":"6","key":"10.1016\/j.imbio.2021.152153_b0290","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5830\/CVJA-2015-028","article-title":"Comparison of a qualitative measurement of heart-type fatty acid-binding protein with other cardiac markers as an early diagnostic marker in the diagnosis of non-ST-segment elevation myocardial infarction","volume":"26","author":"Gerede","year":"2015","journal-title":"Cardiovasc J Afr"},{"issue":"8","key":"10.1016\/j.imbio.2021.152153_b0295","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/07853890.2020.1800075","article-title":"Heart-type fatty acid-binding protein: an overlooked cardiac biomarker","volume":"52","author":"Goel","year":"2020","journal-title":"Ann. Med."},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0300","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12265-013-9462-3","article-title":"New and emerging biomarkers in left ventricular systolic dysfunction\u2013insight into dilated cardiomyopathy","volume":"6","author":"Gopal","year":"2013","journal-title":"J Cardiovasc Transl Res"},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0305","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/0001555576305309","article-title":"Increased collagen propeptides in the skin of a scleredema patient but no change in re-epithelialisation rate","volume":"76","author":"Haapasaari","year":"1996","journal-title":"Acta Derm. Venereol."},{"issue":"8","key":"10.1016\/j.imbio.2021.152153_b0310","first-page":"705","article-title":"Clinical Relevance of matrix metalloproteinase 9 in patients with acute coronary syndrome","volume":"21","author":"Hamed","year":"2015","journal-title":"Clin Appl Thromb Off J Int Acad Clin Appl Thromb"},{"issue":"6","key":"10.1016\/j.imbio.2021.152153_b0315","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1159\/000368474","article-title":"Diagnostic and prognostic utility of neutrophil gelatinase-associated lipocalin (NGAL) in patients with cardiovascular diseases\u2013review","volume":"39","author":"Helanova","year":"2014","journal-title":"Kidney Blood Press Res"},{"issue":"7","key":"10.1016\/j.imbio.2021.152153_b0320","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.imbio.2021.152153_b0325","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/GIM.0b013e3181f2481f","article-title":"Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals","volume":"12","author":"Hershberger","year":"2010","journal-title":"Genet. Med."},{"issue":"9","key":"10.1016\/j.imbio.2021.152153_b0330","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"issue":"21","key":"10.1016\/j.imbio.2021.152153_b0335","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.jacc.2016.09.937","article-title":"The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy","volume":"68","author":"Heymans","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.imbio.2021.152153_b0340","doi-asserted-by":"crossref","unstructured":"Hladinova Z, Hruskova Z, Svobodova B, Malickova K, Lanska V, Konop\u00e1sek P, et al. Increased Levels of Soluble ST2 in Patients with Active Newly Diagnosed ANCA-Associated Vasculitis. Cantarini L, editor. Mediators Inflamm [Internet]. 2015;2015:603750. Available from: https:\/\/doi.org\/10.1155\/2015\/603750.","DOI":"10.1155\/2015\/603750"},{"key":"10.1016\/j.imbio.2021.152153_b0345","doi-asserted-by":"crossref","unstructured":"Hongisto M, Lassus J, Tarvasm\u00e4ki T, Sionis A, Sans-Rosello J, Tolppanen H, et al. Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study. ESC Hear Fail. 2021 Jan.","DOI":"10.1002\/ehf2.13224"},{"issue":"5","key":"10.1016\/j.imbio.2021.152153_b0350","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/cvr\/cvz026","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors","volume":"115","author":"Hu","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.imbio.2021.152153_b0355","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2147\/DMSO.S295088","article-title":"Increased Serum Cystatin C Levels Were Associated with Depressive Symptoms in Patients with Type 2 Diabetes","volume":"14","author":"Huang","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pin.12868","article-title":"Inflammation in myocardial disease: From myocarditis to dilated cardiomyopathy","volume":"70","author":"Imanaka\u2010Yoshida","year":"2020","journal-title":"Pathol. Int."},{"issue":"16","key":"10.1016\/j.imbio.2021.152153_b0365","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.3390\/ijms21165689","article-title":"Galectin-3, N-terminal Propeptides of Type I and III Procollagen in Patients with Atrial Fibrillation and Metabolic Syndrome","volume":"21","author":"Ionin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.imbio.2021.152153_b0370","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.imbio.2021.152153_b0375","doi-asserted-by":"crossref","unstructured":"Jordan E, Peterson L, Ai T, Asatryan B, Bronicki L, Brown E, et al. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy. Circulation [Internet]. 2021\/05\/05. 2021 Jul 6;144(1):7\u201319. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33947203.","DOI":"10.1161\/CIRCULATIONAHA.120.053033"},{"issue":"10","key":"10.1016\/j.imbio.2021.152153_b0380","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1475-2840-10-37","article-title":"Heart-type fatty acid binding protein (H-FABP): relationship with arterial intima-media thickness and role as diagnostic marker for atherosclerosis in patients with \u0131mpaired glucose metabolism","volume":"2","author":"Karbek","year":"2011","journal-title":"Cardiovasc Diabetol [Internet]"},{"issue":"13","key":"10.1016\/j.imbio.2021.152153_b0385","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1134\/S0006297913130063","article-title":"Human cardiac troponin complex","volume":"78","author":"Katrukha","year":"2013","journal-title":"Structure and functions Biochemistry (Mosc)"},{"issue":"3","key":"10.1016\/j.imbio.2021.152153_b0390","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/eurjhf\/hfs179","article-title":"Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure","volume":"15","author":"Kaye","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.imbio.2021.152153_b0395","article-title":"Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives. Med Sci (Basel","author":"Khan","year":"2018","journal-title":"Switzerland) [Internet]"},{"issue":"6","key":"10.1016\/j.imbio.2021.152153_b0400","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001826","article-title":"Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study","volume":"10","author":"Kinnamon","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"issue":"3","key":"10.1016\/j.imbio.2021.152153_b0405","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12098-020-03524-4","article-title":"Dilated Cardiomyopathy in a Child with COVID-19","volume":"88","author":"Kishore","year":"2021","journal-title":"Indian Journal of Pediatrics"},{"key":"10.1016\/j.imbio.2021.152153_b0410","doi-asserted-by":"crossref","unstructured":"Koch C, Buono S, Menuet A, Rob\u00e9 A, Djeddi S, Kretz C, et al. Myostatin: a Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients. Mol Ther-Methods Clin Dev [Internet]. 2020 Jun 12;17:1178\u201389. Available from: https:\/\/doi.org\/10.1016\/j.omtm.2020.04.022.","DOI":"10.1016\/j.omtm.2020.04.022"},{"key":"10.1016\/j.imbio.2021.152153_b0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/2872607","article-title":"Prognostic Role of Elevated Myeloperoxidase in Patients with Acute Coronary Syndrome: A Systemic Review and Meta-Analysis","volume":"2019","author":"Kolodziej","year":"2019","journal-title":"Mediators Inflamm."},{"issue":"18","key":"10.1016\/j.imbio.2021.152153_b0420","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.3390\/ijms21186742","article-title":"Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis","volume":"21","author":"Krebber","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.imbio.2021.152153_b0425","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/CIRCHEARTFAILURE.110.960716","article-title":"Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy","volume":"4","author":"Krum","year":"2011","journal-title":"Circ. Heart Fail."},{"issue":"3","key":"10.1016\/j.imbio.2021.152153_b0430","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.159.3.9805060","article-title":"Type III and type I procollagen markers in fibrosing alveolitis","volume":"159","author":"Lammi","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.imbio.2021.152153_b0435","doi-asserted-by":"crossref","first-page":"e0202406","DOI":"10.1371\/journal.pone.0202406","article-title":"Predictive value of soluble ST2 in adolescent and adult patients with complex congenital heart disease","volume":"13","author":"Laqqan","year":"2018","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.imbio.2021.152153_b0440","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurjhf\/hfs092","article-title":"Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials","volume":"14","author":"Latini","year":"2012","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.imbio.2021.152153_b0445","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1741826711402735","article-title":"Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure","volume":"19","author":"Lenk","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.imbio.2021.152153_b0450","doi-asserted-by":"crossref","unstructured":"Lesizza P, Aleksova A, Ortis B, Beltrami AP, Giacca M, Sinagra G. Regenerative Medicine and Biomarkers for Dilated Cardiomyopathy. In: Sinagra G, Merlo M, Pinamonti B, editors. Cham (CH); 2019. p. 173\u2013185.","DOI":"10.1007\/978-3-030-13864-6_11"},{"issue":"5","key":"10.1016\/j.imbio.2021.152153_b0455","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.CIR.100.5.461","article-title":"Desmin mutation responsible for idiopathic dilated cardiomyopathy","volume":"100","author":"Li","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0460","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/ijms22010043","article-title":"New Potential Biomarkers for Chronic Kidney Disease Management\u2014A Review of the Literature","volume":"22","author":"Lousa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.imbio.2021.152153_b0465","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/aps.2018.38","article-title":"Current and future circulating biomarkers for cardiac amyloidosis","volume":"39","author":"Luciani","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.imbio.2021.152153_b0470","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00059-020-04900-8","article-title":"Inflammatory dilated cardiomyopathy : Etiology and clinical managementInflammatorische dilatative Kardiomyopathie: \u00c4tiologie und klinisches Management","volume":"45","author":"Maisch","year":"2020","journal-title":"Herz"},{"issue":"7","key":"10.1016\/j.imbio.2021.152153_b0475","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2010.08.644","article-title":"\u03b2-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure","volume":"57","author":"Manzano-Fern\u00e1ndez","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.imbio.2021.152153_b0480","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3390\/ijms21082696","article-title":"Structure and Function of Filamin C in the Muscle Z-Disc","volume":"21","author":"Mao","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.imbio.2021.152153_b0485","doi-asserted-by":"crossref","first-page":"129628","DOI":"10.1016\/j.bbagen.2020.129628","article-title":"The multiple activities of BAG3 protein: Mechanisms","volume":"1864","author":"Marzullo","year":"2020","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"10.1016\/j.imbio.2021.152153_b0490","doi-asserted-by":"crossref","unstructured":"Matilla L, Arrieta V, Jover E, Garcia-Pe\u00f1a A, Martinez-Martinez E, Sadaba R, et al. Soluble St2 Induces Cardiac Fibroblast Activation and Collagen Synthesis via Neuropilin-1. Cells. 2020 Jul;9(7).","DOI":"10.3390\/cells9071667"},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0495","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1253\/circj.CJ-12-0999","article-title":"Elevated serum heart-type fatty acid-binding protein in the convalescent stage predicts long-term outcome in patients surviving acute myocardial infarction","volume":"77","author":"Matsumoto","year":"2013","journal-title":"Circ. J."},{"issue":"8","key":"10.1016\/j.imbio.2021.152153_b0500","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1161\/ATVBAHA.114.303465","article-title":"Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study","volume":"34","author":"Matsushita","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.imbio.2021.152153_b0505","doi-asserted-by":"crossref","first-page":"e93460","DOI":"10.1371\/journal.pone.0093460","article-title":"Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery","volume":"9","author":"Meersch","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imbio.2021.152153_b0510","doi-asserted-by":"crossref","unstructured":"Mendes MA, de Carvalho DS, Amadeu TP, Silva BJ de A, Prata RB da S, da Silva CO, et al. Elevated Pentraxin-3 Concentrations in Patients With Leprosy: Potential Biomarker of Erythema Nodosum Leprosum. J Infect Dis [Internet]. 2017 Dec 19;216(12):1635\u201343. Available from: https:\/\/doi.org\/10.1093\/infdis\/jix267.","DOI":"10.1093\/infdis\/jix267"},{"issue":"2","key":"10.1016\/j.imbio.2021.152153_b0515","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1103","article-title":"Evolving concepts in dilated cardiomyopathy","volume":"20","author":"Merlo","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.imbio.2021.152153_b0520","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tem.2007.11.001","article-title":"Copeptin: clinical use of a new biomarker","volume":"19","author":"Morgenthaler","year":"2008","journal-title":"Trends Endocrinol Metab [Internet]"},{"issue":"9","key":"10.1016\/j.imbio.2021.152153_b0525","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/eurheartj\/ehn071","article-title":"Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18","volume":"29","author":"Morrow","year":"2008","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0530","first-page":"253","article-title":"The cardio-protective signaling and mechanisms of adiponectin","volume":"2","author":"Nanayakkara","year":"2012","journal-title":"Am J Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0535","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jacc.2008.03.050","article-title":"Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease","volume":"52","author":"Neuhold","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.imbio.2021.152153_b0540","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/eurheartj\/ehp004","article-title":"Prognostic value of apoptosis markers in advanced heart failure patients","volume":"30","author":"Niessner","year":"2009","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.imbio.2021.152153_b0545","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1253\/circj.CJ-10-1083","article-title":"Relationship between biological variation in B-type natriuretic peptide and plasma renin concentration in stable outpatients with dilated cardiomyopathy","volume":"75","author":"Nishiyama","year":"2011","journal-title":"Circ. J."},{"issue":"16","key":"10.1016\/j.imbio.2021.152153_b0550","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jacc.2013.12.034","article-title":"Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-T","volume":"63","author":"O\u2019Malley","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.imbio.2021.152153_b0555","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.imbio.2021.152153_b0560","doi-asserted-by":"crossref","first-page":"e94834","DOI":"10.1371\/journal.pone.0094834","article-title":"Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study","volume":"9","author":"Otaki","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0565","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.amjcard.2015.03.043","article-title":"Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure","volume":"116","author":"Palazzuoli","year":"2015","journal-title":"Am. J. Cardiol."},{"issue":"23","key":"10.1016\/j.imbio.2021.152153_b0570","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.jacc.2009.07.041","article-title":"Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction","volume":"54","author":"Pascual-Figal","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0575","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000343897","article-title":"Relative Change in NT-proBNP Level: An Important Risk Predictor of Cardiovascular Congestion in Haemodialysis Patients","volume":"2","author":"Pastural-Thaunat","year":"2012","journal-title":"Nephron Extra"},{"key":"10.1016\/j.imbio.2021.152153_b0580","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clinbiochem.2019.07.014","article-title":"Long-term prognostic value of growth differentiation factor-15 in acute coronary syndromes","volume":"73","author":"Peir\u00f3","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.imbio.2021.152153_b0585","doi-asserted-by":"crossref","unstructured":"P\u00e9rez de Ciriza C, Lawrie A, Varo N. Osteoprotegerin in Cardiometabolic Disorders. Iervasi G, editor. Int J Endocrinol [Internet]. 2015;2015:564934. Available from: https:\/\/doi.org\/10.1155\/2015\/564934.","DOI":"10.1155\/2015\/564934"},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0590","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.hlc.2019.11.018","article-title":"Familial Dilated Cardiomyopathy","volume":"29","author":"Peters","year":"2020","journal-title":"Heart Lung Circ"},{"issue":"23","key":"10.1016\/j.imbio.2021.152153_b0595","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.imbio.2021.152153_b0600","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1097\/HJH.0b013e3283316c4d","article-title":"Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure","volume":"27","author":"Plaksej","year":"2009","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0605","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10741-020-09913-3","article-title":"The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review","volume":"26","author":"Rabkin","year":"2021","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.imbio.2021.152153_b0610","doi-asserted-by":"crossref","first-page":"106857","DOI":"10.1016\/j.vph.2021.106857","article-title":"A possible role for ST2 as prognostic biomarker for COVID-19","volume":"138","author":"Ragusa","year":"2021","journal-title":"Vasc.Pharmacol."},{"key":"10.1016\/j.imbio.2021.152153_b0615","doi-asserted-by":"crossref","unstructured":"Rathore M, Girard C, Ohanna M, Tichet M, Ben Jouira R, Garcia E, et al. Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)\/NF-\u03baB signaling pathway. Oncogene [Internet]. 2019;38(30):5873\u201389. Available from: https:\/\/doi.org\/10.1038\/s41388-019-0848-9.","DOI":"10.1038\/s41388-019-0848-9"},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0620","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/joim.12944","article-title":"Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: A translational review of current literature","volume":"286","author":"Reichart","year":"2019","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.imbio.2021.152153_b0625","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fimmu.2019.00823","article-title":"Pentraxin 3 in Cardiovascular Disease","volume":"10","author":"Ristagno","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.imbio.2021.152153_b0630","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41569-019-0284-0","article-title":"Genetics of dilated cardiomyopathy: practical implications for heart failure management","volume":"17","author":"Rosenbaum","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"10.1016\/j.imbio.2021.152153_b0635","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrcardio.2009.130","article-title":"Vascular dysfunction in idiopathic dilated cardiomyopathy","volume":"6","author":"Roura","year":"2009","journal-title":"Nat. Rev. Cardiol."},{"issue":"10","key":"10.1016\/j.imbio.2021.152153_b0640","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ejheart.2007.07.008","article-title":"Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation","volume":"9","author":"Roura","year":"2007","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.imbio.2021.152153_b0645","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.atherosclerosis.2013.08.009","article-title":"New insights into lipid raft function regulating myocardial vascularization competency in human idiopathic dilated cardiomyopathy","volume":"230","author":"Roura","year":"2013","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0650","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000353294","article-title":"The challenges for cardiac vascular precursor cell therapy: lessons from a very elusive precursor","volume":"50","author":"Roura","year":"2013","journal-title":"J. Vasc. Res."},{"issue":"3","key":"10.1016\/j.imbio.2021.152153_b0655","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ijcard.2014.07.270","article-title":"Inverse relationship between raft LRP1 localization and non-raft ERK1,2\/MMP9 activation in idiopathic dilated cardiomyopathy: potential impact in ventricular remodeling","volume":"176","author":"Roura","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.imbio.2021.152153_b0660","doi-asserted-by":"crossref","unstructured":"Roura Ferrer S, Perez-Quevedo RC, Galvez-Monton C, Nasarre L, Marti V, Astier L, et al. Idiopathic dilated cardiomyopathy shows increased distribution of low-density lipoprotein receptor-related protein 1 into membrane lipid rafts. Eur Heart J [Internet]. 2013 Aug 1;34(suppl_1). Available from: https:\/\/doi.org\/10.1093\/eurheartj\/eht309.2795.","DOI":"10.1093\/eurheartj\/eht309.2795"},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0665","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12265-015-9671-z","article-title":"Circulating endothelial progenitor cells: potential biomarkers for idiopathic dilated cardiomyopathy","volume":"9","author":"Roura","year":"2016","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.imbio.2021.152153_b0670","article-title":"Idiopathic Dilated Cardiomyopathy: Molecular Basis and Distilling Complexity to Advance","author":"Roura","year":"2017","journal-title":"In"},{"issue":"11","key":"10.1016\/j.imbio.2021.152153_b0675","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1111\/jcmm.13211","article-title":"Extracellular vesicles do not contribute to higher circulating levels of soluble LRP1 in idiopathic dilated cardiomyopathy","volume":"21","author":"Roura","year":"2017","journal-title":"J. Cell Mol. Med."},{"issue":"10","key":"10.1016\/j.imbio.2021.152153_b0680","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/heartjnl-2011-301260","article-title":"Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes","volume":"98","author":"R\u00f8ysland","year":"2012","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0685","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cyto.2015.01.020","article-title":"Osteoprotegerin concentrations in patients with suspected reversible myocardial ischemia: observations from the Akershus Cardiac Examination (ACE) 1 Study","volume":"73","author":"R\u00f8ysland","year":"2015","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0690","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2310\/JIM.0b013e3182880c11","article-title":"Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy","volume":"61","author":"Sarli","year":"2013","journal-title":"J. Investig. Med."},{"issue":"13","key":"10.1016\/j.imbio.2021.152153_b0695","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/01.CIR.0000091085.12422.19","article-title":"Impaired VE-cadherin\/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy","volume":"108","author":"Sch\u00e4fer","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0700","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"6","key":"10.1016\/j.imbio.2021.152153_b0705","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00059-007-3046-4","volume":"32","author":"Schulz-Menger","year":"2007","journal-title":"Herz"},{"issue":"2","key":"10.1016\/j.imbio.2021.152153_b0710","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/ijms19020379","article-title":"Galectin-3: one molecule for an alphabet of diseases, from A to Z","volume":"19","author":"Sciacchitano","year":"2018","journal-title":"Int. J. Mol. Sci. [Internet]"},{"key":"10.1016\/j.imbio.2021.152153_b0715","doi-asserted-by":"crossref","unstructured":"Seddon J, Kasprowicz V, Walker NF, Yuen HM, Sunpath H, Tezera L, et al. Procollagen III N-terminal Propeptide and Desmosine are Released by Matrix Destruction in Pulmonary Tuberculosis. J Infect Dis [Internet]. 2013 Nov 15;208(10):1571\u20139. Available from: https:\/\/doi.org\/10.1093\/infdis\/jit343.","DOI":"10.1093\/infdis\/jit343"},{"issue":"5-6","key":"10.1016\/j.imbio.2021.152153_b0720","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12265-016-9713-1","article-title":"Soluble ST2 and risk of arrhythmias, heart failure, or death in patients with mildly symptomatic heart failure: results from MADIT-CRT","volume":"9","author":"Skali","year":"2016","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"3","key":"10.1016\/j.imbio.2021.152153_b0725","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.numecd.2020.11.014","article-title":"Soluble ST2 proteins in male cachectic patients with chronic heart failure","volume":"31","author":"Sobieszek","year":"2021","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"issue":"4","key":"10.1016\/j.imbio.2021.152153_b0730","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","article-title":"Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function","volume":"87","author":"Spinale","year":"2007","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.imbio.2021.152153_b0735","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/0016-5085(92)90314-O","article-title":"Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn\u2019s disease","volume":"102","author":"Stallmach","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imbio.2021.152153_b0740","doi-asserted-by":"crossref","unstructured":"Staubli SM, Sch\u00e4fer J, Rosenthal R, Zeindler J, Oertli D, Nebiker CA. The role of CRP and Pentraxin 3 in the prediction of systemic inflammatory response syndrome and death in acute pancreatitis. Sci Rep [Internet]. 2019;9(1):18340. Available from: https:\/\/doi.org\/10.1038\/s41598-019-54910-8.","DOI":"10.1038\/s41598-019-54910-8"},{"key":"10.1016\/j.imbio.2021.152153_b0745","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062955","article-title":"The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies","author":"Stege","year":"2021","journal-title":"Int J Mol Sci [Internet]"},{"issue":"5","key":"10.1016\/j.imbio.2021.152153_b0750","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/FJC.0000000000000217","article-title":"Effect of carvedilol on serum heart-type fatty acid-binding protein, brain natriuretic peptide, and cardiac function in patients with chronic heart failure","volume":"65","author":"Sun","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"8","key":"10.1016\/j.imbio.2021.152153_b0755","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/jmg.2004.023283","article-title":"In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients","volume":"42","author":"Sylvius","year":"2005","journal-title":"J. Med. Genet."},{"issue":"10","key":"10.1016\/j.imbio.2021.152153_b0760","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/eurheartj\/ehm011","article-title":"Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM)","volume":"28","author":"Theiss","year":"2007","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.imbio.2021.152153_b0765","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijcard.2007.02.004","article-title":"Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy","volume":"124","author":"Timonen","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.imbio.2021.152153_b0770","doi-asserted-by":"crossref","unstructured":"Tokito A, Jougasaki M. Matrix Metalloproteinases in Non-Neoplastic Disorders. Int J Mol Sci [Internet]. 2016 21;17(7):1178. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27455234.","DOI":"10.3390\/ijms17071178"},{"issue":"3","key":"10.1016\/j.imbio.2021.152153_b0775","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"19","key":"10.1016\/j.imbio.2021.152153_b0780","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1161\/01.CIR.0000165119.62099.14","article-title":"Dysregulated osteoprotegerin\/RANK ligand\/RANK axis in clinical and experimental heart failure","volume":"111","author":"Ueland","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.imbio.2021.152153_b0785","first-page":"1282","article-title":"Increased soluble CD95 (sFas\/CD95) serum level correlates with poor prognosis in melanoma patients","volume":"7","author":"Ugurel","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.imbio.2021.152153_b0790","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/01.CIR.0000136813.89036.21","article-title":"CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure","volume":"110","author":"Valgimigli","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0795","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00109-004-0589-1","article-title":"Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A\/C mutations portend a high risk of sudden death?","volume":"83","author":"van Berlo","year":"2005","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.imbio.2021.152153_b0800","doi-asserted-by":"crossref","unstructured":"Vesely DL. Atrial natriuretic peptides in pathophysiological diseases. Cardiovasc Res [Internet]. 2001 Sep 1;51(4):647\u201358. Available from: https:\/\/doi.org\/10.1016\/S0008-6363(01)00256-5.","DOI":"10.1016\/S0008-6363(01)00256-5"},{"issue":"5","key":"10.1016\/j.imbio.2021.152153_b0805","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1378\/chest.13-0922","article-title":"\u03b2-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment","volume":"144","author":"V\u00edlchez","year":"2013","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.imbio.2021.152153_b0810","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/eurheartj\/ehp098","article-title":"C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study","volume":"30","author":"Voors","year":"2009","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.imbio.2021.152153_b0815","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ihj.2015.06.035","article-title":"Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain","volume":"67","author":"Vupputuri","year":"2015","journal-title":"Indian Heart J."},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0820","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-020-01744-2","article-title":"The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"issue":"7","key":"10.1016\/j.imbio.2021.152153_b0825","first-page":"1346","article-title":"Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: A meta-analysis","volume":"37","author":"Wang","year":"2019","journal-title":"Am. J. Emerg. Med."},{"issue":"10092","key":"10.1016\/j.imbio.2021.152153_b0830","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.imbio.2021.152153_b0835","unstructured":"WHO. Cardiovascular disease. 2019;[2020-12-2."},{"issue":"11","key":"10.1016\/j.imbio.2021.152153_b0840","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","article-title":"Growth\/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint","volume":"19","author":"Wischhusen","year":"2020","journal-title":"Front Immunol [Internet]"},{"key":"10.1016\/j.imbio.2021.152153_b0845","doi-asserted-by":"crossref","unstructured":"Wong CW, Teo BW, Lamoureux E, Ikram MK, Wang JJ, Tai ES, et al. Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes. Chiarelli F, editor. J Diabetes Res [Internet]. 2015;2015:404280. Available from: https:\/\/doi.org\/10.1155\/2015\/404280.","DOI":"10.1155\/2015\/404280"},{"issue":"2","key":"10.1016\/j.imbio.2021.152153_b0850","doi-asserted-by":"crossref","first-page":"E327","DOI":"10.1532\/hsf.3547","article-title":"Galectin-3 in predicting mortality of heart failure: a systematic review and meta-analysis","volume":"24","author":"Wu","year":"2021","journal-title":"Heart Surg. Forum"},{"issue":"2","key":"10.1016\/j.imbio.2021.152153_b0855","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejheart.2007.12.002","article-title":"Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure","volume":"10","author":"Yan","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.imbio.2021.152153_b0860","doi-asserted-by":"crossref","unstructured":"Yang HS, Woo JE, Lee SJ, Park SH, Woo JM. Elevated Plasma Pentraxin 3 Levels Are Associated With Development and Progression of Diabetic Retinopathy in Korean Patients With Type 2 Diabetes Mellitus. Invest Ophthalmol Vis Sci [Internet]. 2014 Sep 23;55(9):5989\u201397. Available from: https:\/\/doi.org\/10.1167\/iovs.14-14864.","DOI":"10.1167\/iovs.14-14864"},{"key":"10.1016\/j.imbio.2021.152153_b0865","doi-asserted-by":"crossref","unstructured":"Yin X, Cao H, Wei Y, Li H-H. Alteration of the IL-33-sST2 pathway in hypertensive patients and a mouse model. Hypertens Res [Internet]. 2019;42(11):1664\u201371. Available from: https:\/\/doi.org\/10.1038\/s41440-019-0291-x.","DOI":"10.1038\/s41440-019-0291-x"},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0870","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15864","article-title":"Myosin 7 and its adaptors link cadherins to actin","volume":"8","author":"Yu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imbio.2021.152153_b0875","article-title":"Prognostic value of circulating sST2 for the prediction of mortality in patients with cardiac light-chain amyloidosis","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Cardiovasc Med."},{"issue":"3","key":"10.1016\/j.imbio.2021.152153_b0880","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/CIRCHEARTFAILURE.110.958199","article-title":"Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure","volume":"4","author":"Zile","year":"2011","journal-title":"Circ. Heart Fail."},{"issue":"1","key":"10.1016\/j.imbio.2021.152153_b0885","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002551","article-title":"Plasma biomarkers reflecting profibrotic processes in heart failure with a preserved ejection fraction: data from the prospective comparison of ARNI With ARB on management of heart failure with preserved ejection fraction study","volume":"9","author":"Zile","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.imbio.2021.152153_b0890","doi-asserted-by":"crossref","unstructured":"Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol. 2001 Jul;12(7):1508\u201315.","DOI":"10.1681\/ASN.V1271508"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298521001017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298521001017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:49:42Z","timestamp":1759250982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298521001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":178,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0171298521001017"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2021.152153","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic biomarkers of dilated cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2021.152153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152153"}}